UNSPSC 51142419: Dotarizine

This classification denotes a serotonin antagonist and calcium channel blocker with the molecular formula C29H34N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IO7663S6D3, chemically known as 1-(diphenylmethyl)-4-(3-(2-phenyl-1,3-dioxolan-2-yl)propyl)piperazine but generally known as dotarizine, which bears US NIH Compound Identifier 55285. European Medicines Agency schedules Dotarizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06378MIG.

UNSPSC 51142419 Dotarizine, a Commodity code, does not appear in recent state and local procurement activity. The three recent opportunities tagged under this code involve naloxone acquisition, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products—none of which concern dotarizine specifically. The code designation appears to be a misclassification in the source data, as the actual procurements involve different pharmaceutical product classes and supply-chain arrangements that fall outside the nominal scope of dotarizine procurement.

State and local issuing bodies show no measurable recent activity under this code. Without evidence of active opportunities aligned to dotarizine acquisition, assessment of issuing-body concentration, geographic distribution, or procurement momentum cannot be grounded in current market signals.